Predictors of Paravalvular Leakage After Transcatheter Aortic Valve Replacement in Patients With BAV: A Machine Learning Model.

Journal: JACC. Advances
Published Date:

Abstract

BACKGROUND: The specific anatomy of bicuspid aortic valve (BAV) increases the incidence of ≥ mild paravalvular leakage (PVL) after transcatheter aortic valve replacement (TAVR). OBJECTIVES: The purpose of this study was to develop and validate a model for predicting post-TAVR PVL in patients with BAV. METHODS: A total of 1,080 patients (373 cases with type 0 and 707 cases with type 1) undergoing TAVR were analyzed. The random forest (RF) model was established to predict PVL. Logistic regression analysis was used to investigate predictive differentiation and accuracy values based on the receiver-operating characteristic curve. Additionally, 109 cases further verified the reliability and stability of the model. RESULTS: The RF model of the derivation data set produced 7 predictors, including the corrected calcification volume (Corr-CV) of leaflets, the Corr-CV of annular surroundings, the Corr-CV of the left ventricular outflow tract, the perimeter of the left ventricular outflow tract, the plane/perimeter of the supra-annular plane, horizontal aorta, annular ellipticity, and postdilation. The area under the curve (AUC), accuracy, sensitivity, and specificity of the RF and the logistic model were 0.982, 0.994, 0.997, 0.993, and 0.978, 0.951, 0.917, 0.957, respectively. The AUC of the RF model in the validation data set was 0.975, whereas the AUC of the logistic analysis model was 0.988. Furthermore, the decision curve analysis and clinical impact curve analysis verified the clinical applicability and net benefit. CONCLUSIONS: The machine learning model with 7 predictors effectively identifies post-TAVR PVL risk in patients with BAV stenosis, aiding procedural planning and PVL prevention. (Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease; NCT05044338).

Authors

  • Yu Mao
    Department of Radiology, The Affiliated Hospital of Southwest Medical University, No. 23 Tai Ping Street, Luzhou, 646000, Sichuan, China.
  • Yang Liu
    Department of Computer Science, Hong Kong Baptist University, Hong Kong, China.
  • Mengen Zhai
    Department of Cardiovascular Surgery, Xijing Hospital, Air Force Medical University, Xi'an, China.
  • Ping Jin
    Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Fangyao Chen
    Department of Epidemiology and Health Statistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi 710061, China.
  • Gejun Zhang
    Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Lai Wei
  • Jian Liu
    Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Yingqiang Guo
    Department of Cardiovascular Surgery, West China Hospital, Chengdu, China.
  • Yongjian Wu
  • Jian Yang
    Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.

Keywords

No keywords available for this article.